Company Encyclopedia
View More
name
Hob Biotech
688656.SH
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.
1.613 T
688656.SHMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
C
BiotechnologyIndustry
Industry Ranking35/80
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE4.46%C
    • Profit Margin9.40%B
    • Gross Margin59.14%B
  • Growth ScoreD
    • Revenue YoY-3.44%D
    • Net Profit YoY3.32%C
    • Total Assets YoY-3.75%D
    • Net Assets YoY2.86%C
  • Cash ScoreC
    • Cash Flow Margin1063.64%B
    • OCF YoY-3.44%D
  • Operating ScoreC
    • Turnover0.39C
  • Debt ScoreA
    • Gearing Ratio14.11%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    HOB Biotech Ties Up With Roche China's Unit to Market Testing Kits

    HOB Biotech Ties Up With Roche China's Unit to Market Testing Kits

    marketscreener·
    SH
    688656
    +1.00%
    marketscreener·
    SH
    688656
    +1.00%

    Hob Biotech collaborates with Roche Diagnostics in the field of chemiluminescent autoantibody detection products

    Hob Biotech and Roche Diagnostics signed a cooperation framework agreement, and both parties will collaborate in the field of chemiluminescent self-antibody testing products. This initiative aims to enhance Hob Biotech's brand recognition in the domestic market and expand its market share in the diagnostic reagent field. Although the agreement is a framework statement, specific cooperation projects need to be signed separately, and there is uncertainty in the implementation and advancement

    Zhitong·
    SH
    688656
    +1.00%
    Zhitong·
    SH
    688656
    +1.00%

    HOB Biotech Shanghai Subsidiary Enrolls First Patient in Clinical Trial for Anti-Allergy Product

    HOB Biotech's Shanghai subsidiary has enrolled its first patient in a phase 3 clinical trial for its MM09 sublingual desensitization spray targeting allergies from house dust mites. The company has also secured import permits for the drug in Hong Kong and Macao for cat and dog hair allergens. Following this news, shares rose by 1% in late afternoon trading on Wednesday.

    marketscreener·
    SH
    688656
    +1.00%
    marketscreener·
    SH
    688656
    +1.00%

    Hob Biotech: MM09 sublingual spray Phase III clinical trial completes enrollment of the first batch of subjects

    Hob Biotech has signed an exclusive strategic cooperation agreement with Inmunotek to introduce the Oraltek® series of desensitization drugs into the Chinese market. The company's wholly-owned subsidiary, Shanghai Hob Biotech, has successfully completed the enrollment of the first batch of subjects for the Phase III clinical trial of the MM09 sublingual spray. In addition, three desensitization drugs have obtained clinical urgent import approval in the Guangdong-Hong Kong-Macao Greater Bay Area

    Zhitong·
    SH
    688656
    +1.00%
    Zhitong·
    SH
    688656
    +1.00%

    HOB Biotech Group Corp.,Ltd(XSSC:688656) added to S&P Global BMI Index

    HOB Biotech Group Corp.,Ltd(XSSC:688656) added to S&P Global BMI Index

    marketscreener·
    SH
    688656
    +1.00%
    marketscreener·
    SH
    688656
    +1.00%